Roxbury Financial LLC Astrazeneca PLC Transaction History

Roxbury Financial LLC

$104 Billion
Q4 2024

A detailed history of Roxbury Financial LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Roxbury Financial LLC holds 171 shares of AZN stock, worth $13,031. This represents 0.01% of its overall portfolio holdings.

Number of Shares

171

Holding current value

$13,031

% of portfolio

0.01%

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Jan 30, 2025	BUY	$63.2 - $79.58 $10,807 - $13,608	171 New	171 $11.6 Million

Others Institutions Holding AZN

# of Institutions

1,365

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

Price T Rowe Associates Inc Baltimore, MD

60.4M
Shares

$4.6 Billion
0.46% of portfolio
Primecap Management CO Pasadena, CA

41M
Shares

$3.13 Billion
2.12% of portfolio
Capital International Investors Los Angeles, CA

37.5M
Shares

$2.86 Billion
0.48% of portfolio
Wellington Management Group LLP Boston, MA

37M
Shares

$2.82 Billion
0.46% of portfolio
Bank Of America Corp Charlotte, NC

24M
Shares

$1.83 Billion
0.13% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $236B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roxbury Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roxbury Financial LLC with notifications on news.

Account